Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 5
1998 6
1999 1
2000 1
2001 1
2002 4
2003 1
2006 2
2007 2
2008 2
2009 1
2010 1
2011 1
2012 4
2013 2
2014 2
2015 1
2016 3
2017 1
2018 1
2019 1
2020 2
2021 1
2022 3
2023 3
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

51 results

Results by year

Filters applied: . Clear all
Page 1
Ublituximab versus Teriflunomide in Relapsing Multiple Sclerosis.
Steinman L, Fox E, Hartung HP, Alvarez E, Qian P, Wray S, Robertson D, Huang D, Selmaj K, Wynn D, Cutter G, Mok K, Hsu Y, Xu Y, Weiss MS, Bosco JA, Power SA, Lee L, Miskin HP, Cree BAC; ULTIMATE I and ULTIMATE II Investigators. Steinman L, et al. N Engl J Med. 2022 Aug 25;387(8):704-714. doi: 10.1056/NEJMoa2201904. N Engl J Med. 2022. PMID: 36001711 Clinical Trial.
Association of circadian rhythm genes ARNTL/BMAL1 and CLOCK with multiple sclerosis.
Lavtar P, Rudolf G, Maver A, Hodžić A, Starčević Čizmarević N, Živković M, Šega Jazbec S, Klemenc Ketiš Z, Kapović M, Dinčić E, Raičević R, Sepčić J, Lovrečić L, Stanković A, Ristić S, Peterlin B. Lavtar P, et al. Among authors: dincic e. PLoS One. 2018 Jan 11;13(1):e0190601. doi: 10.1371/journal.pone.0190601. eCollection 2018. PLoS One. 2018. PMID: 29324865 Free PMC article.
[The Fahr syndrome].
Raicević R, Jovicić A, Djordjević D, Dincić E, Marković Lj. Raicević R, et al. Among authors: dincic e. Vojnosanit Pregl. 1998 Mar-Apr;55(2):219-23. Vojnosanit Pregl. 1998. PMID: 9623350 Serbian.
[The blood-brain barrier].
Dincić E, Jovicić A, Magdić B, Popović P, Dordević D, Raicević R. Dincić E, et al. Vojnosanit Pregl. 2002 Nov-Dec;59(6):633-41. doi: 10.2298/vsp0206633d. Vojnosanit Pregl. 2002. PMID: 12557622 Review. Serbian. No abstract available.
Alemtuzumab improves preexisting disability in active relapsing-remitting MS patients.
Giovannoni G, Cohen JA, Coles AJ, Hartung HP, Havrdova E, Selmaj KW, Margolin DH, Lake SL, Kaup SM, Panzara MA, Compston DA; CARE-MS II Investigators. Giovannoni G, et al. Neurology. 2016 Nov 8;87(19):1985-1992. doi: 10.1212/WNL.0000000000003319. Epub 2016 Oct 12. Neurology. 2016. PMID: 27733571 Free PMC article. Clinical Trial.
51 results